Ajanta Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 17, 2025
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma held its 46th AGM on July 17, 2025 via video conference, lasting one hour from 11:00 AM to 12:00 PM. Chairman Mr. Mannalal Agrawal presided over the meeting, with all directors, and statutory and secretarial auditors in attendance. A total of 66 shareholders participated (6 from promoter group and 60 from public). Six resolutions were tabled, including adoption of financial statements for FY25, confirmation of interim dividend as final, re-appointment of Mr. Rajesh M. Agrawal and Mr. Madhusudan B. Agrawal, appointment of new secretarial auditors, and ratification of cost auditors' remuneration. Audit reports contained no qualifications or adverse remarks. E-voting results will be disclosed to stock exchanges within two working days.
This is a routine regulatory filing confirming the AGM was held in compliance with SEBI rules. No material negative news — audit reports are clean, and the resolutions appear largely procedural. Investors should watch for the e-voting results for shareholder approval levels, but no immediate price impact is expected.